Lack of Efficacy of Fadrozole in Treating Precocious Puberty in Girls with the McCune-Albright Syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 12, 2003, Pages 5730-5733

  Nunez, Susan B ^c   Calis, Karim ^b   Cutler Jr , Gordon B ^d   Jones, Janet ^b   Feuillan, Penelope P ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANASTROZOLE; AROMATASE INHIBITOR; CORTISONE; DESLORELIN; ESTROGEN; FADROZOLE; GONADORELIN AGONIST; LETROZOLE;

ABDOMINAL PAIN; ADRENAL INSUFFICIENCY; ALBRIGHT SYNDROME; ARTICLE; BODY WEIGHT DISORDER; BONE MATURATION; BREAST CANCER; CHILD; CLINICAL ARTICLE; CONSTIPATION; DOSE TIME EFFECT RELATION; ELECTROLYTE DISTURBANCE; ESTROGEN ACTIVITY; FATIGUE; FEMALE; HUMAN; MENSTRUATION; MUSCLE WEAKNESS; ORTHOSTATIC HYPOTENSION; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; SALT CRAVING; SIDE EFFECT; STEROIDOGENESIS; WEIGHT REDUCTION;

AGE DETERMINATION BY SKELETON; AGING; AROMATASE INHIBITORS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; ESTRADIOL; ESTRONE; FADROZOLE; FEMALE; FIBROUS DYSPLASIA, POLYOSTOTIC; GONADOTROPIN-RELEASING HORMONE; GROWTH; HUMANS; MENSTRUATION; OVARY; PUBERTY, PRECOCIOUS; TREATMENT FAILURE; TRIPTORELIN;

EID: 0347993152     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030864     Document Type: Article

References (19)

1. Albright F, Butler AM, Hampton AO, Smith P 1937 Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction with precocious puberty in females: report of five cases. N Engl J Med 216:727-746
2. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Speigel AM 1991 Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325:1688-1695
3. Foster CM, Ross JL, Pescovitz OH, Loriaux DL, Cutler Jr G, Comite F 1984 Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndrome. J Clin Endocrinol Metab 58:1161-1165
4. Comite F, Shawker TH, Pescovitz OH, Loriaux DL, Cutler Jr G 1984 Cyclic ovarian function resistant to treatment with luteinizing hormone releasing hormone in girls with McCune-Albright syndrome. J Clin Endocrinol Metab 59:801-805
5. Steele VE, Mellor LB, Sawyer WK, Wasvary JM, Brown LJ 1987 In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A. Steroids 50:147-161
6. Santen RJ, Demers LM, Adlercreutz H, Harvey H, Santner S, Sanders S, Lipton A 1989 Inhibition of aromatase with CGS 16949A in postmenopausal women. J Clin Endocrinol Metab 68:99-104
7. Falkson G, Raats JI, Falkson HC 1992 Fadrozole hydrochloride, a new non-toxic aromatase inhibitor for the treatment of patients with metastatic breast cancer. J Steroid Biochem Mol Biol 43:161-165
8. Demers LM, Lipton A, Harvey HA, Hanagan J, Mulagha MT, Santen RJ 1993 The effects of long-term fadrozole hydrochloride treatment in patients with advanced stage breast cancer. J Steroid Biochem Mol Biol 44:683-685
9. Trunet PF, Mueller PH, Girard F 1992 The effects of fadrozole hydrochloride on aldosterone secretion in healthy male subjects. J Clin Endocrinol Metab 74:571-576
10. Sample WF, Lippe BM, Gypes MT 1977 Grey scale ultrasonography of the normal female pelvis. Radiology 125:477-483
11. Greulich WW, Pyle SI 1950 Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford, CA: Stanford University Press
12. Loriaux DL, Ruder HJ, Lipsett MB 1972 Measurement of estrone sulfate in plasma. Steroids 18:463-472
13. Nieschlag E, Loriaux DL 1972 Radioimmunoassay for plasma testosterone. Z Klin Chem Klin Biochem 10:164-168
14. Cutler Jr G, Glenn M, Bush M, Hodgen GB, Graham CE, Loriaux DL 1978 Adrenarche: a survey of rodents, domestic animals and primates. Endocrinology 103:2112-2118
15. Odell WD, Ross GT, Rayford PL 1967 Radioimmunoassay for luteinizing hormone in human plasma or serum: physiological studies. J Clin Invest 46:248-255
16. Cargille CM, Rayford PL 1970 Characterization of antisera for human follicle-stimulating hormone radioimmunoassay. J Lab Clin Med 175:1030-1040
17. Menan J, Catt KJ 1972 Measurement of renin activity concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinology 98:422-430
18. Leschek EW, Jones J, Barnes KM, Hill SC, Cutler Jr GB 1999 Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty. J Clin Endcrinol Metab 84:175-178
19. Bhatagnar AS, Hausler A, Schieweck K, Lang M, Bowman R 1990 Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new, nonsteroidal aromatase inhibitor. J Steroid Biochem Mol Biol 37:1021-1027